Login / Signup

Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study.

Abigail SchulzNatalie HuynhMargaret HegerMustafa Bakir
Published in: Molecular and cellular pediatrics (2024)
Our data suggests that RDV is safe in children, with no reported serious AEs. However, the absence of a control group limits the extent to which conclusions can be drawn. RDV may contribute to clinical improvement, particularly in high-risk patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • sars cov
  • liver failure
  • young adults
  • prognostic factors
  • respiratory failure
  • intensive care unit
  • machine learning
  • hepatitis b virus
  • combination therapy